Skip to main content
SpringerLink
Log in

Nuklearmedizinische Diagnostik und Therapie in der Uroonkologie

  • Living reference work entry
  • First Online:
Uroonkologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 98 Accesses

Zusammenfassung

Nuklearmedizinische Untersuchungen basieren auf den Tracer-Prinzip, d. h. den Patienten wird eine kleine Menge eines radioaktiv markierten Pharmakons appliziert, gefolgt von einer Messung der Verteilung der Radioaktivität mit einem hochempfindlichen Detektorsystem. Dieses Untersuchungsprinzip ermöglicht eine nichtinvasive Visualisierung von Stoffwechselvorgängen und wird oft mit dem Term „molecular imaging“ gleichgesetzt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Afshar-Oromieh A, Malcher A, Eder M et al (2013) PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40:486–495

    Article  CAS  PubMed  Google Scholar 

  • Ahmadzadehfar H, Rahbar K, Kürpig S et al (2015) Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study. EJNMMI Res 5(1):114

    PubMed  Google Scholar 

  • Ahmadzadehfar H, Albers P, Bockisch A et al (2018) Lutetium-177-PSMA radioligand therapy : consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein. Urologe A 57(6):709–713

    Article  CAS  PubMed  Google Scholar 

  • Albrecht S, Buchegger F, Soloviev D et al (2007) (11)C-acetate PET in the early evaluation of prostate cancer recurrence. Eur J Nucl Med Mol Imaging 34:185–196

    Article  PubMed  Google Scholar 

  • Baczyk M, Czepczyński R, Milecki P, Pisarek M, Oleksa R, Sowiński J (2007) 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma. Nucl Med Commun 28:245–250

    Article  PubMed  Google Scholar 

  • Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Loidl W, Broinger G, Stoiber F, Fogelman I, Langsteger W (2008) Detection of bone metastases in patients with prostate cancer by F-18 fluorocholine and F-18 fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging 35(10):1766–1774 [Epub 05.05.2008]

    Article  PubMed  Google Scholar 

  • Beyer T, Freudenberg LS, Townsend DW, Czernin J (2011a) The future of hybrid imaging. Part 1: hybrid imaging technologies and SPECT/CT. Insights Imaging 2:161–169

    Article  PubMed  PubMed Central  Google Scholar 

  • Beyer T, Freudenberg LS, Czernin J, Townsend DW (2011b) The future of hybrid imaging. Part 3: PET/MR, small animal imaging and beyond. Insights Imaging 2(3):235–246

    Article  PubMed  PubMed Central  Google Scholar 

  • Bockisch A, Kühl H, Freudenberg L, Antoch G, Mueller S, Forsting M (2006) PET/CT – Evolution oder Revolution in der onkologischen Diagnostik? Dtsch Arztebl 103(5):A-249

    Google Scholar 

  • Bouchelouche K, Oehr P (2008) Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol 179:34–45

    Article  CAS  PubMed  Google Scholar 

  • Brenot-Rossi I, Rossi D, Esterni B, Brunelle S, Chuto G, Bastide C (2008) Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure. Eur J Nucl Med Mol Imaging 35(1):32–38

    Article  PubMed  Google Scholar 

  • Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G (2012) Oncologic PET/MRI, Part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis. J Nucl Med 53(6):928–938 [Epub ahead of print]

    Article  PubMed  Google Scholar 

  • Burton JB, Johnson M, Sato M, Koh SB, Mulholland DJ, Stout D, Chatziioannou AF, Phelps ME, Wu H, Wu L (2008) Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nat Med 14(8):882–888 [Epub 11.07.2008]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheetham PJ, Petrylak DP (2012) Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation. Oncology 26:330–337

    PubMed  Google Scholar 

  • Colabufo NA, Abate C, Contino M, Inglese C, Niso M, Berardi F, Perrone R (2007) PB183, a sigma receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma. Bioorg Med Chem Lett 15:1990–1993

    Google Scholar 

  • Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gönen M, Ruan S, Pierre C, Nagel A, Pryma DA, Humm J, Larson SM, Old LJ, Russo P (2007) Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 8:304–310

    Article  CAS  PubMed  Google Scholar 

  • Dolezal J, Vizda J, Odrazka K (2007) Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer. Urol Int 78:50–57

    Article  CAS  PubMed  Google Scholar 

  • Garrison JC, Rold TL, Sieckman GL, Figueroa SD, Volkert WA, Jurisson SS, Hoffman TJ (2007) In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems. J Nucl Med 48:1327–1337

    Article  CAS  PubMed  Google Scholar 

  • Giovacchini G, Picchio M, Coradeschi E, Scattoni V, Bettinardi V, Cozzarini C, Freschi M, Fazio F, Messa C (2008) [(11)C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Eur J Nucl Med Mol Imag 35:1065–1073

    Article  CAS  Google Scholar 

  • Hadway P, Smith Y, Corbishley C, Heenan S, Watkin NA (2007) Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int 100:561–565

    Article  PubMed  Google Scholar 

  • Heyns CF, Theron PD (2008) Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes. BJU Int 102(3):305–309 [Epub 10.04.2008]

    Article  PubMed  Google Scholar 

  • Husarik DB, Miralbell R, Dubs M, John H, Giger OT, Gelet A, Cservenyàk T, Hany TF (2008) Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 35:253–263

    Article  PubMed  Google Scholar 

  • Igerc I, Kohlfürst S, Gallowitsch HJ, Matschnig S, Kresnik E, Gomez-Segovia I, Lind P (2008) The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer. Eur J Nucl Med Mol Imaging 35:976–983

    Article  CAS  PubMed  Google Scholar 

  • Jambor I, Borra R, Kemppainen J, Lepomäki V, Parkkola R, Dean K, Alanen K, Arponen E, Nurmi M, Aronen HJ, Minn H (2012) Improved detection of localized prostate cancer using co-registered MRI and (11)C-acetate PET/CT. Eur J Radiol 81(11):2966–2972 [Epub ahead of print]

    Article  PubMed  Google Scholar 

  • Jeschke S, Beri A, Grüll M, Ziegerhofer J, Prammer P, Leeb K, Sega W, Janetschek G (2008) Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol 53:126–132

    Article  PubMed  Google Scholar 

  • Kratochwil C, Bruchertseifer F, Giesel FL, Weis M, Verburg FA, Mottaghy F, Kopka K, Apostolidis C, Haberkorn U, Morgenstern A (2016) 225Ac-PSMA-617 for PSMA-targeted a-radiation therapy of metastatic castration-resistant prostate cancer. J Nucl Med 57:1–4

    Article  CAS  Google Scholar 

  • Krengli M, Ballarè A, Cannillo B, Rudoni M, Kocjancic E, Loi G, Brambilla M, Inglese E, Frea B (2006) Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 15(66):1100–1104

    Article  Google Scholar 

  • Larson SM, Schöder H (2008) Advances in positron emission tomography applications for urologic cancers. Curr Opin Urol 18:65–70

    Article  PubMed  Google Scholar 

  • Leijte JA, Olmos RA, Nieweg OE, Horenblas S (2008) Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection. Eur Urol 54(4):885–890 [Epub 19.05.2008]

    Article  PubMed  Google Scholar 

  • Liedberg F, Chebil G, Davidsson T, Gudjonsson S, Månsson W (2006) ntraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol 175:84–88

    Article  PubMed  Google Scholar 

  • Lord M, Ratib O, Vallée JP (2011) 18F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer. Eur J Nucl Med Mol Imaging 38(12):2288

    Article  PubMed  Google Scholar 

  • Meinhardt W, Valdés Olmos RA, van der Poel HG, Bex A, Horenblas S (2008) Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations. BJU Int 102(6):714–717 [Epub 10.04.2008]

    Article  PubMed  Google Scholar 

  • Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, Kubo Y, Noda A, Nakamura Y, Nishimura S, Tsuji A (2008) Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter. J Nucl Med 49:615–622

    Article  CAS  PubMed  Google Scholar 

  • Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, Yachnin J, Garkavij M, Strang P, Harmenberg J, Bolstad B, Bruland OS (2007) Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. Lancet Oncol 8(7):587–594

    Article  CAS  PubMed  Google Scholar 

  • Park H, Wood D, Hussain H, Meyer CR, Shah RB, Johnson TD, Chenevert T, Piert M (2012) Introducing parametric fusion PET/MRI of primary prostate cancer. J Nucl Med 53(4):546–551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parker C, Nilsson S, Heinrich D et al (2013) Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 369:213–223

    Article  CAS  PubMed  Google Scholar 

  • Pelosi E, Arena V, Skanjeti A et al (2008) Role whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer. Radiol Med 113:895–904

    Article  CAS  PubMed  Google Scholar 

  • Perera M, Papa N, Roberts M et al (2019) Gallium-68 Prostate-specific membrane antigen positron emission tomography in advanced prostate cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. Eur Urol. https://doi.org/10.1016/j.eururo.2019.01.049

  • Poeppel, TD, Andreeff M, Becherer A, Bockisch A.; Fricke E, Geworski L, Heinzel A, Krause B,J, Krause T, Mitterhauser M, Scheidhauer K, Schenck M, Sonnenschein W Gabriel M (2015) DGN-Handlungsempfehlung (S1-Leitlinie) Radionuklidtherapie von Knochenmetastasen mittels Radium-223 Stand: 10/2015 – AWMF-Registernummer: 031-053 A

    Google Scholar 

  • Ricci S, Boni G, Pastina I, Genovesi D, Cianci C, Chiacchio S, Orlandini C, Grosso M, Alsharif A, Chioni A, Di Donato S, Francesca F, Selli C, Rubello D, Mariani G (2007) Clinical benefit of bone-targeted radiometabolic therapy with combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer. Eur J Nucl Med Mol Imaging 34:1023–1030

    Article  CAS  PubMed  Google Scholar 

  • Rinnab L, Blumstein N, Mottaghy F et al (2007) 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer. BJU Int 99:1421–1426

    Article  CAS  PubMed  Google Scholar 

  • Rioja J, Rodríguez-Fraile M, Lima-Favaretto R, Rincón-Mayans A, Peñuelas-Sánchez I, Zudaire-Bergera JJ, Parra RO (2010) Role of positron emission tomography in urological oncology. BJU Int 106(11):1578–1593

    Article  PubMed  Google Scholar 

  • Scattoni V, Picchio M, Suardi N et al (2007) Detection of lymph-node metastases with integrated [(11)C] choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 52:423–429

    Article  PubMed  Google Scholar 

  • Schiavina R, Scattoni V, Castellucci P, Picchio M, Corti B, Briganti A, Franceschelli A, Sanguedolce F, Bertaccini A, Farsad M, Giovacchini G, Fanti S, Grigioni WF, Fazio F, Montorsi F, Rigatti P, Martorana G (2008) (11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 54:392–401

    Article  PubMed  Google Scholar 

  • Schilling D, Schlemmer HP, Wagner PH, Böttcher P, Merseburger AS, Aschoff P, Bares R, Pfannenberg C, Ganswindt U, Corvin S, Stenzl A (2008) Histological verification of (11)C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int 102(4):446–451 [Epub am 10.04.2008]

    Article  PubMed  Google Scholar 

  • Sherif A, Garske U, de la Torre M, Thörn M (2006) Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 50:83–91

    Article  PubMed  Google Scholar 

  • Takahashi N, Inoue T, Lee J, Yamaguchi T, Shizukuishi K (2007) The roles of PET and PET/CT in the diagnosis and management of prostate cancer. Oncology 72:226–233

    Article  PubMed  Google Scholar 

  • Townsend DW (2008) Dual-modality imaging: combining anatomy and function. J Nucl Med 49:938–955

    Article  PubMed  Google Scholar 

  • Vāvere AL, Kridel SJ, Wheeler FB, Lewis JS (2008) 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med 49:327–334

    Article  CAS  PubMed  Google Scholar 

  • Warncke SH, Mattei A, Fuechsel FG, Z'Brun S, Krause T, Studer UE (2007) Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol 52:126–132

    Article  PubMed  Google Scholar 

  • Weckermann D, Holl G, Dorn R, Wagner T, Harzmann R (2007a) Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer. BJU Int 99:1036–1040

    Article  PubMed  Google Scholar 

  • Weckermann D, Dorn R, Holl G, Wagner T, Harzmann R (2007b) Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 51:1549–1556

    Article  PubMed  Google Scholar 

  • Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R (2007c) Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol 177:916–920

    Article  PubMed  Google Scholar 

  • Willhauck MJ, Sharif Samani BR, Gildehaus FJ, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Göke B, Morris JC, Spitzweg C (2007) Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. J Clin Endocrinol Metab 92:4451–4458

    Article  CAS  PubMed  Google Scholar 

  • Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Göke B, Morris JC, Spitzweg C (2008) The potential of (211) Astatine for NIS-mediated radionuclide therapy in prostate cancer. Eur J Nucl Med Mol Imaging 35:1272–1281

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Nuklearmedizin, Universitätsklinikum Essen, Essen, Deutschland

    Ken Herrmann & Andreas Bockisch

  2. ZRN Rheinland, Grevenbroich, Deutschland

    Lutz S. Freudenberg

Authors
  1. Ken Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Bockisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lutz S. Freudenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ken Herrmann .

Editor information

Editors and Affiliations

  1. Helios Marien Klinikum Duisburg, Duisburg, Nordrhein-Westfalen, Germany

    Herbert Rübben

  2. Urologische Klinik/Poliklinik, Universitätsklinikum Rostock, Rostock, Mecklenburg-Vorpommern, Germany

    Oliver Hakenberg

  3. Klinik und Poliklinik für Urologie, Universitätsklinikum Jena, Jena, Thüringen, Germany

    Marc-Oliver Grimm

  4. Caritaskrankenhaus St. Josef, Regensburg, Germany

    Maximilian Burger

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Herrmann, K., Bockisch, A., Freudenberg, L.S. (2020). Nuklearmedizinische Diagnostik und Therapie in der Uroonkologie. In: Rübben, H., Hakenberg, O., Grimm, MO., Burger, M. (eds) Uroonkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54652-9_16-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54652-9_16-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54652-9

  • Online ISBN: 978-3-662-54652-9

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation